Munger Mode rating: 2 out of 5 — Sell. Our own rating from the research report below, on business quality first: moat durability and management, with price separating the top three.
Price used: about $171.50, the reported close on 2026-10-20 after the Q3 report. The 52-week high is $183.78, set in August 2026. We took the numbers straight from the September 30, 2026 10-Q and set them against the post-earnings price. The business is better than the stock's reputation after PFAS and the Solventum spin-off. Management has done real work. At roughly 19 times the company's own raised 2026 adjusted EPS of $9.10–$9.15, the price already pays for that work, and the adjusted figure leaves out costs that come out of owners' pockets. Our reasoning in brief: Business quality is decent but not wonderful. 3M has real technical depth, thousands of qualified-in specifications, and a global distribution reach. But organic growth runs at 2–3%, and the portfolio is a collection of good niches, not one dominant franchise.
Recent filings analysed: 8-K (2026-11-04), 8-K (2026-10-20), 10-Q (2026-10-20), 8-K (2026-10-19).
Stock screener · Superinvestor 13F holdings · Analyst sentiment